Related Experiment Videos
New drug targets in inflammation and immunomodulation
1Norman Consulting, Burnham, Bucks, UK.
Drug News & Perspectives
|June 19, 2003
Summary
This conference highlighted new molecular targets for anti-inflammatory agents, showcasing novel data in disease biology and medicinal chemistry. Future meetings will likely incorporate more genomics-driven research for drug discovery.
Area of Science:
- Inflammatory diseases
- Medicinal chemistry
- Molecular biology
Background:
- The conference program covered diverse aspects of inflammatory disease biology and medicinal chemistry.
- Recent advancements in identifying and pursuing new molecular targets for anti-inflammatory drug development were presented.
Purpose of the Study:
- To present and discuss topical, often unpublished, data on the biology and medicinal chemistry of inflammatory diseases.
- To highlight novel molecular targets for the development of new anti-inflammatory agents.
Main Methods:
- Presentations by speakers on current research in the field.
- Well-informed discussions following each presentation.
Main Results:
- A wide array of current data was shared, with many presentations followed by insightful discussions.
- Two main topics were emphasized, showcasing the pursuit of new molecular targets for anti-inflammatory therapies.
Conclusions:
- The conference successfully presented cutting-edge research in inflammatory disease biology and medicinal chemistry.
- A notable observation was the limited use of genomics in identifying drug targets, suggesting a future shift towards this approach.